← All Coeptis Therapeutics Holdings, INC filings

Coeptis Therapeutics Holdings, INC 8-K filings

NASDAQ
COEP
Coeptis Therapeutics Holdings, INC
8-K: Coeptis Therapeutics Faces Nasdaq Delisting Risk After Share Price Falls Below $1.00
Coeptis Therapeutics Holdings, Inc. received a notice from Nasdaq for failing to maintain a minimum share price of $1.00, placing its listing status at risk.